Literature DB >> 2537306

Properties of a cGMP-dependent monomeric protein kinase from bovine aorta.

L Wolfe1, S H Francis, J D Corbin.   

Abstract

A form of cGMP-dependent protein kinase (cGK) that was different from previously described cGK was purified from bovine aorta smooth muscle. The partial amino-terminal sequencing of this enzyme indicated that it was derived by endogenous proteolysis of the type I beta isozyme of cGK. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, this form migrated as a smaller protein (Mr = 70,000) than the parent cGK (Mr = 80,000), and since the calculated nondenatured Mr was approximately 89,000 compared to Mr = 170,000 for the dimeric native enzyme, it represented a monomeric form of cGK. The monomer bound approximately 2 mol of [3H]cGMP per mol of monomer, although it had only one rapid component in [3H]cGMP dissociation assays as compared to one rapid and one slow component for the native cGK. The specific catalytic activity of the kinase was similar to that of the native enzyme, suggesting that the catalytic domain was essentially intact. The monomeric cGK incorporated significant 32P when incubated with Mg2+ and [gamma-32P]ATP in the presence of cGMP, although the phosphorylation proceeded at a slower rate than that obtained with native cGK. In contrast to previous reports of monomeric forms of cGK, this monomer was highly cGMP-dependent, although it had a slightly higher Ka (0.8 microM) for cGMP than that of the native enzyme (0.4 microM) and a low Hill coefficient of 1.0 (1.6 for the native enzyme). The cGMP dependence of the monomer did not decrease with dilution, implying that the cGMP dependence was not due to monomer-monomer interactions in the assay. The results indicated that the catalytic domain, cGMP binding domain(s), and inhibitory domain of cGK interact primarily within the same subunit rather than between subunits of the dimer as previously hypothesized for dimeric cGK.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537306

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Probing noncovalent protein-ligand interactions of the cGMP-dependent protein kinase using electrospray ionization time of flight mass spectrometry.

Authors:  Martijn W H Pinkse; Albert J R Heck; Klaus Rumpel; Frank Pullen
Journal:  J Am Soc Mass Spectrom       Date:  2004-10       Impact factor: 3.109

Review 2.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

3.  The amino terminus of cGMP-dependent protein kinase Iβ increases the dynamics of the protein's cGMP-binding pockets.

Authors:  Jun H Lee; Sheng Li; Tong Liu; Simon Hsu; Choel Kim; Virgil L Woods; Darren E Casteel
Journal:  Int J Mass Spectrom       Date:  2011-04-30       Impact factor: 1.986

Review 4.  The cGMP-dependent protein kinase--gene, protein, and function.

Authors:  E Butt; J Geiger; T Jarchau; S M Lohmann; U Walter
Journal:  Neurochem Res       Date:  1993-01       Impact factor: 3.996

5.  Huntingtin-associated protein 1 (HAP1) is a cGMP-dependent kinase anchoring protein (GKAP) specific for the cGMP-dependent protein kinase Iβ isoform.

Authors:  Eleonora Corradini; Pepijn P Burgers; Michael Plank; Albert J R Heck; Arjen Scholten
Journal:  J Biol Chem       Date:  2015-02-04       Impact factor: 5.157

6.  Crystal structure of cGMP-dependent protein kinase reveals novel site of interchain communication.

Authors:  Brent W Osborne; Jian Wu; Caitlin J McFarland; Christian K Nickl; Banumathi Sankaran; Darren E Casteel; Virgil L Woods; Alexandr P Kornev; Susan S Taylor; Wolfgang R Dostmann
Journal:  Structure       Date:  2011-09-07       Impact factor: 5.006

Review 7.  A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases.

Authors:  Alexander Y Kots; Emil Martin; Iraida G Sharina; Ferid Murad
Journal:  Handb Exp Pharmacol       Date:  2009

8.  Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP.

Authors:  G A Soff; T L Cornwell; D L Cundiff; S Gately; T M Lincoln
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

9.  Co-crystal structures of PKG Iβ (92-227) with cGMP and cAMP reveal the molecular details of cyclic-nucleotide binding.

Authors:  Jeong Joo Kim; Darren E Casteel; Gilbert Huang; Taek Hun Kwon; Ronnie Kuo Ren; Peter Zwart; Jeffrey J Headd; Nicholas Gene Brown; Dar-Chone Chow; Timothy Palzkill; Choel Kim
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.